The Compatibility of Nivestim(TM) Under Cytotoxic Chemotherapy in the Treatment of Malignant Diseases
To observe the tolerability, safety and efficacy of preventative treatment using NivestimTM
in patients receiving cytotoxic chemotherapy for cancer.
To investigate the description of the characteristics of patients being treated with
NivestimTM, the treatment modalities using NivestimTM in the daily Routine, to investigate
the description of the characteristics of the participating Physicians and to determine the
general prescription practices of these physicians with regard to G-CSF.
Observational Model: Cohort, Time Perspective: Prospective
Number of hospitalizations
Any incidence of hospitalization due to febrile neutropenia and/or infection will be evaluated. Individual cases will be reported and documented on SAE forms by the repsonsible physician.
Germany: Federal Institute for Drugs and Medical Devices